Page last updated: 2024-08-22

sulfadoxine and 2019 Novel Coronavirus Disease

sulfadoxine has been researched along with 2019 Novel Coronavirus Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Amone, J; Dall'Oglio, G; De Vita, E; Di Gennaro, F; Fantoni, M; Iacobelli, V; Ictho, J; L'Episcopia, M; Lochoro, P; Marotta, C; Murri, R; Ngole, B; Ogwang, J; Okori, S; Olal, L; Onapa, E; Putoto, G; Saracino, A; Segala, FV; Severini, C1
Arya, A; Chaudhry, S; Foko, LPK; Hawadak, J; Kumar, A; Nana, RRD; Singh, V1
Boncy, J; Chang, MA; Fouché, B; Gaul, DA; Green, M; Holmes, K; Juin, S; Kheradmand, T; LaFortune, W; Marseille, S; Moore, SG; Rigodon, J; Rogier, E; Telfort, MA1

Reviews

1 review(s) available for sulfadoxine and 2019 Novel Coronavirus Disease

ArticleYear
Intermittent preventive treatment with Sulfadoxine pyrimethamine for malaria: a global overview and challenges affecting optimal drug uptake in pregnant women.
    Pathogens and global health, 2023, Volume: 117, Issue:5

    Topics: Antimalarials; COVID-19; Drug Combinations; Female; Humans; Malaria; Pharmaceutical Preparations; Pregnancy; Pregnancy Complications, Parasitic; Pregnant Women; Pyrimethamine; Sulfadoxine

2023

Other Studies

2 other study(ies) available for sulfadoxine and 2019 Novel Coronavirus Disease

ArticleYear
Impact of antimalarial resistance and COVID-19 pandemic on malaria care among pregnant women in Northern Uganda (ERASE): protocol of a prospective observational study.
    BMC infectious diseases, 2022, Aug-04, Volume: 22, Issue:1

    Topics: Antimalarials; Artemisinins; COVID-19; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Observational Studies as Topic; Pandemics; Pregnancy; Pregnant Women; Prospective Studies; Pyrimethamine; Retrospective Studies; Sulfadoxine; Uganda

2022
Investigation of Four Cases of Stevens-Johnson Syndrome among Participants in a Mass Drug Administration Campaign with Sulfadoxine-Pyrimethamine and Primaquine in Haiti, 2020.
    The American journal of tropical medicine and hygiene, 2023, 06-07, Volume: 108, Issue:6

    Topics: Antimalarials; COVID-19; Drug Combinations; Haiti; Humans; Malaria; Mass Drug Administration; Pandemics; Primaquine; Pyrimethamine; SARS-CoV-2; Stevens-Johnson Syndrome; Sulfadoxine

2023